Vaxcyte (PCVX)
Developer of high-valency bacterial vaccine candidates using cell-free protein synthesis.
$56.12
vs last close−2.90 (−4.91%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$2.12
Revenue estimate
$12.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.02−$1.04−$1.22−$1.56−$1.80−$2.30−$1.97Pending
Estimate−$1.16−$1.02−$1.12−$1.27−$1.53−$1.78−$2.06−$2.12
Surprise+12.1%−2.0%−8.9%−22.8%−17.7%−29.4%+4.4%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————$18.8M$12.5M$12.5M$12.5M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.64 | — | — |
| Sep 2027 | −$0.56 | — | — |
| Jun 2027 | −$1.24 | — | — |
| Mar 2027 | −$1.38 | — | — |
| Dec 2026 | −$2.07 | — | — |
| Nov 2026 | −$2.12 | — | — |
| Aug 2026 | −$2.06 | −$1.97 | +4.4% |
| May 2026 | −$1.78 | −$2.30 | −29.4% |
| Feb 2026 | −$1.53 | −$1.80 | −17.7% |
| Nov 2025 | −$1.27 | −$1.56 | −22.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Mar 2020 | |||
| Jun 2020 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.64 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.56 | — | — | $0 | — | — | — |
| Jun 2027 | −$1.24 | — | — | $0 | — | — | — |
| Mar 2027 | −$1.38 | — | — | $0 | — | — | — |
| Dec 2026 | −$2.07 | — | — | $12.5M | — | — | — |
| Nov 3, 2026 | −$2.12 | — | — | $12.5M | — | — | — |
| Aug 5, 2026 | −$2.06 | −$1.97 | +4.4% | $12.5M | — | — | +5.3% |
| May 6, 2026 | −$1.78 | −$2.30 | −29.4% | $12.5M | — | — | −9.8% |
| Feb 24, 2026 | −$1.53 | −$1.80 | −17.7% | $18.8M | — | — | +2.8% |
| Nov 4, 2025 | −$1.27 | −$1.56 | −22.8% | — | — | — | −3.5% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 25, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 12, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Jun 15, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |